Key result
RAVIN support facilitates routine rotavirus vaccine introduction in 5 Gavi-eligible countries.
Why the study?
Despite WHO recommendations to introduce rotavirus vaccines, only 81 countries had done so by 2015, leaving millions of children at risk for rotavirus morbidity and mortality.
The RAVIN project successfully supported five out of eight targeted Gavi-eligible countries in introducing the rotavirus vaccine into their national immunization programs between 2016 and 2020.
Technical assistance aided rotavirus introductions in five of eight Gavi countries; leaves open scalability and long-term impact in additional settings.
Despite the 2009 World Health Organization recommendation that all countries introduce rotavirus vaccines (RVV) into their national immunization programs, just 81 countries had introduced RVV by the end of 2015, leaving millions of children at risk for rotavirus morbidity and mortality. In response, the Rotavirus Accelerated Vaccine Introduction Network (RAVIN) was established in 2016 to provide support to eight Gavi-eligible countries that had yet to make an RVV introduction decision and/or had requested technical assistance with RVV preparations: Afghanistan, Bangladesh, Benin, Cambodia, Democratic Republic of Congo, Lao People's Democratic Republic, Myanmar, and Nepal. During 2016-2020, RAVIN worked with country governments and partners to support evidence-based immunization decision-making, RVV introduction preparation and implementation, and multilateral coordination. By the September 2020 program close-out, five of the eight RAVIN focus countries successfully introduced RVV into their routine childhood immunization programs. We report on the RAVIN approach, describe how the project responded collectively to an evolving RVV product landscape, synthesize common characteristics of the RAVIN country experiences, highlight key lessons learned, and outline the unfinished agenda to inform future new vaccine introduction efforts by countries and global partners.
No takes yet. Share an insight, caveat, or question.
Jennings et al. (2023) studied Rotavirus vaccine introduction. Rotavirus Accelerated Vaccine Introduction Network (RAVIN) support was evaluated on Introduction of rotavirus vaccines into routine childhood immunization programs. The Rotavirus Accelerated Vaccine Introduction Network (RAVIN) supported 8 Gavi-eligible countries, with 5 successfully introducing rotavirus vaccines into their routine programs by September 2020.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: